Gritstone Bio GRTS is a clinical-stage biotechnology company focused on developing vaccines targeting multiple indications, including cancer. In the past week, the company’s stock lost 57.5%. This ...
Looking for stocks with high upside potential? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief look at what statistics have to say about hedge ...
Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Gritstone bio, Inc. (“Gritstone” or the “Company”) (NASDAQ: GRTS) on behalf of investors concerning the ...
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of all purchasers of securities of Gritstone bio, Inc.
GRTS COVID-19 vaccine can use two components, a chimpanzee adenovirus ((ChAd)) and self-amplifying mRNA (samRNA). Pfizer (PFE) and BioNTech (BNTX) as well as Moderna (MRNA) both used mRNA in their ...
Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is exempt of filing insider holdings with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback